SureTrader SureTrader
Home > Boards > US Listed > Biotechs >

Vascular Biogenics Ltd. (VBLT)

VBLT RSS Feed
Add VBLT Price Alert      Hide Sticky   Hide Intro
Moderator: gr8db8
Search This Board:
Last Post: 9/22/2016 10:19:17 PM - Followers: 28 - Board type: Free - Posts Today: 0
Vascular Biogenics Ltd is an Israel-based clinical-stage biopharmaceutical company. The Company is engaged in the discovery, development and commercialization of treatments for cancer and immune-inflammatory diseases. Its clinical pipeline is based on two platform technologies that leverage the body’s natural physiologic and genetic regulatory elements. As of June 6, 2014, it has developed two programs based on these platforms an oncology program and an anti-inflammatory program. Its lead product candidate from its oncology program, VB-111, is a gene-based biologic that is initially developing for recurrent glioblastoma (rGBM), an aggressive form of brain cancer. The Company has also received orphan drug designation in both the United States and Europe. The Company’s oncology program is based on its Vascular Targeting System (VTS), platform technology, which utilizes genetically targeted therapy to destroy newly formed, or angiogenic, blood vessels.

http://www.vblrx.com
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
VBLT
Current Price
Volume:
Bid Ask Day's Range
SureTrader
VBLT News: Report of Foreign Issuer (6-k) 09/21/2016 04:17:16 PM
VBLT News: Amended Statement of Beneficial Ownership (sc 13d/a) 09/20/2016 11:22:46 AM
VBLT News: VBL Therapeutics to Present at the 18th Annual Rodman & Renshaw Global Investment Conference in New York City on September 12... 09/06/2016 08:00:00 AM
VBLT News: Initial Statement of Beneficial Ownership (3) 08/25/2016 11:53:10 AM
VBLT News: Statement of Beneficial Ownership (sc 13d) 08/25/2016 11:47:42 AM
PostSubject
#425  Sticky Note This is a must read Q&A with the CEO. gr8db8 09/17/16 04:32:34 PM
#435   I agree. I think it is effective and davidal66 09/22/16 10:19:17 PM
#434   Nice article and nice info on the drug's gr8db8 09/22/16 09:24:30 PM
#433   VBLT should creep up slowly to $8+ by Lucky40 09/22/16 12:42:14 PM
#432   nice article! thanks raptors1994 09/21/16 04:05:36 PM
#431   http://www.ksat.com/news/cancer-therapy-and-research-center-study-gives-young-mu davidal66 09/20/16 08:43:31 PM
#430   http://marketexclusive.com/vbl-therapeutics-ceo-tells-us-about-their-revolu gr8db8 09/17/16 07:18:08 PM
#429   I do not disagree with you. I think gr8db8 09/17/16 07:16:11 PM
#428   It depends. If you hit say 14 plus davidal66 09/17/16 06:46:46 PM
#427   davidal66 ... I think if that scenario played gr8db8 09/17/16 06:34:27 PM
#426   gr8, what's your guess on the share price davidal66 09/17/16 06:19:55 PM
#425   This is a must read Q&A with the CEO. gr8db8 09/17/16 04:32:34 PM
#424   Neeed Volume Moto260 09/15/16 10:16:57 AM
#423   Breaking out! Ogi1 09/07/16 02:20:35 PM
#422   Thanks for the good due diligence. davidal66 08/26/16 10:53:39 PM
#421   In the 13D filing (page 4 of 7): gr8db8 08/26/16 05:46:45 PM
#420   Not sure either? We get a big spike in mjw007 08/26/16 03:19:27 PM
#419   gr, what does this mean? I read it davidal66 08/26/16 02:52:47 PM
#418   Keffi Group VI LLC defaulted on their loan, gr8db8 08/26/16 01:16:17 AM
#417   About time we made a decent move Big buyer mjw007 08/25/16 11:59:50 AM
#416   $4.47 what a beast! ClearlyStocks 08/25/16 11:55:45 AM
#415   $4.42 ClearlyStocks 08/25/16 11:54:07 AM
#414   $4.29 ClearlyStocks 08/25/16 11:51:48 AM
#413   $4.23 4.8 million shares purchased. ClearlyStocks 08/25/16 11:50:03 AM
#412   $4 huge buy ClearlyStocks 08/25/16 11:49:38 AM
#411   Yes, there are some positive results and the gr8db8 08/21/16 07:30:11 PM
#410   The patient interest is also interesting. If you davidal66 08/20/16 02:21:40 PM
#409   Stanford, UCSF, UCLA among others recruiting for VB-111 gr8db8 08/19/16 06:09:53 PM
#408   Yes, on point two this is correct. I davidal66 08/15/16 08:23:20 PM
#407   Two things I took away from the conf call: gr8db8 08/15/16 07:49:05 PM
#406   No news yet on end of phase II davidal66 08/15/16 03:58:38 PM
#405   IN $VBLT $4.05 Lucky40 08/15/16 12:21:02 PM
#404   Like Avastin, Cloughesy is the lead for VB-111. gr8db8 08/10/16 09:11:48 PM
#403   In regards to "patients will drop out of gr8db8 08/10/16 08:51:05 PM
#402   Good stuff, davidal66! gr8db8 08/10/16 08:43:10 PM
#401   Another thing to think about considering it's open davidal66 08/05/16 04:43:57 PM
#400   Since the phase III VB-111 is open label, davidal66 08/05/16 04:41:48 PM
#399   Any reason why this stock is under $4.00 sawtrader 08/02/16 03:14:40 PM
#398   Thanks that was helpful. The only reason I Prana1 07/23/16 12:45:53 PM
#397   Due Diligence on the short case for VBLT davidal66 07/23/16 12:22:58 AM
#396   Due Diligence on the short case for VBLT davidal66 07/23/16 12:16:04 AM
#395   Due Diligence on the short case for VBLT davidal66 07/22/16 11:31:14 PM
#394   Due Diligence on the short case for VBLT davidal66 07/22/16 11:18:32 PM
#393   Reading through the tweets, he doesn't qualify. davidal66 07/21/16 07:14:09 PM
#392   Trying to do my dd. What's adam f's Prana1 07/21/16 05:18:24 PM
#391   thats the idea.. untill funds get fed up raptors1994 07/19/16 06:58:46 PM
#390   I'll just keep averaging down shjohnson310 07/15/16 10:28:01 PM
#389   Yes it sucked. But there's little medium term davidal66 07/15/16 10:26:45 PM
#388   Well this week sucked shjohnson310 07/15/16 11:25:40 AM
#387   It already has options Prana1 07/06/16 10:32:50 PM
#386   Guys, any thoughts on when options might be davidal66 07/06/16 12:07:56 AM
PostSubject